Tommy Stryjewski, MD

Tommy Stryjewski, MD, is co-founder and chief scientific officer of Pykus Therapeutics. He continues to see patients at Tallman Eye Associates, a private practice in the Boston area.

Articles by Tommy Stryjewski, MD

The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD

ByChristina Y. Weng, MD, MBA, FASRS,Tony Stefater, MD, PhD,Tommy Stryjewski, MD

September 8th 2025

In the debut episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD, about PYK-2101, a biodegradable retinal sealant designed to replace gas and oil tamponades.

Latest Updated Articles

The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD
Published: September 8th 2025 | Updated:

Tommy Stryjewski, MD

Tommy Stryjewski, MD, is co-founder and chief scientific officer of Pykus Therapeutics. He continues to see patients at Tallman Eye Associates, a private practice in the Boston area.

Articles by Tommy Stryjewski, MD

The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD

Latest Updated Articles

Trending on Modern Retina

AAO 2025: Ashkan Abbey on the outcomes of EYP-1901 for AMD and DME

AAO 2025: Inder Paul Singh, MD, shares his experience with the Academy Technician Training Platform

Retina roundup: October 13 to October 17

Empowerment through education: Q&A with Inder Paul Singh, MD

Leadership in action during the 2025 AAO named lectures